← FDA DRUG APPROVALS

FDA NDA · NDA018550

RIMADYL

Sponsor: ROCHE

APPLICATION
NDA018550
TYPE
NDA
ORIGINAL APPROVAL
1987-12-31
LATEST ACTION
1995-02-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

RIMADYLDiscontinued
CARPROFEN 150MG · TABLET · ORAL
RIMADYLDiscontinued
CARPROFEN 100MG · TABLET · ORAL

Approval history

1995-02-27Labeling · Supplement 5AP
1989-07-17Manufacturing (CMC) · Supplement 4 · standardAP
1989-07-17Manufacturing (CMC) · Supplement 3 · standardAP
1987-12-31Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →